Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 49-60 of 2091 results.
"Catheter-related bloodstream infections (CRBSIs) are driven by biofilm formation on catheter surfaces. Poly(2-methoxyethyl acrylate) (PMEA) is a blood-compatible polymer that suppresses protein adsorption and may inhibit bacterial attachment through a non-bactericidal anti-adhesive mechanism" Kariya et al (2026).
"This study aimed to compare CLABSI rates between three-way stopcock (TWS) systems and closed vascular access systems (CVAS) in a pediatric cardiovascular surgery intensive care unit (PCSICU)" Çine et al (2026).
"Most venous access guides/algorithms/tools focus on CLABSI reduction and neonates, leaving gaps in guidance for other components of the care process and other populations" Burek et al (2026).
"Its prognostic role in catheter-related bloodstream infections (CRBSIs) is poorly defined, as most studies have focused on differential time to positivity (DTP) for diagnosis" Zizzo et al (2026).
"Our results support OPAT as an effective and safe strategy for managing P. aeruginosa infections in clinically stable patients" Suárez-Casillas et al (2026).
"Children with IF who were treated with rifaximin experienced fewer CLABSI events, suggesting that rifaximin is a viable option for CLABSI prophylaxis in pediatric IF patients" Johnson et al (2026).
"The study of extractable chemicals is used to evaluate whether a medical device contains harmful substances susceptible to migrate and contaminate the patients they are used in" Le Basle et al (2026).
"This study aimed to develop and evaluate a 3D-printed blood collection model (3DBCM) produced from computed tomography images for the clinical skills training of veterinary students" Bektaş et al (2026).
"Most complications were reported with use of intraosseous (IO) devices. Umbilical vein catheters (UVC) were used primarily after hospital birth while IO devices were used in a wider range of settings. Evidence was insufficient to evaluate the use of peripheral vein catheters during neonatal resuscitation” Kawakami et al (2026).
"ATM/AVI solutions demonstrated prolonged stability under the evaluated conditions, supporting their potential use in OPAT programs via 24 h continuous infusion” Toro Blanch et al (2026).
"Current evidence does not support routine prophylactic anticoagulation for all cancer patients with long-term central venous catheters. However, selected high-risk patients may potentially benefit from individualized thromboprophylaxis” Kania et al (2026).
"A comprehensive evaluation of patient status and CRP levels may help reduce inappropriate antibiotic use in long-term care wards” Funato et al (2026).
